| abstract |
A method of treating a therapeutic condition, comprising: providing a mammal in need of such treatment to at least one compound of formula (I) and formula (II), or pharmaceutically acceptable thereof. Administering an effective amount of a possible isomer, salt, solvate or co-crystal form, wherein the substituent is as defined herein and the therapeutic condition is Cardiovascular or cardiovascular disease or illness, inflammatory disease or illness, respiratory disease or illness, cancer, acute renal failure, astrogliosis, liver, kidney, lung or intestinal fibrosis, Alzheimer's disease, diabetes, diabetic nerve Disorder, rheumatoid arthritis, neurodegenerative disease, neurotoxic disease, systemic lupus erythematosus, multiple sclerosis, osteoporosis, glaucoma, macular degeneration, psoriasis, radiation fibrosis, endothelial disorder, wound or spinal cord injury, or It is their condition or results. Combination therapy with other therapeutically active agents is also disclosed. |